Advances in analytical methods for regulatory complement proteins in research and clinical applications

Area of Science:

• Immunology
• Biochemistry
• Clinical Diagnostics

Background:

• Complement system dysregulation is linked to diseases like age-related macular degeneration and hemolytic uremic syndrome.
• Accurate quantification of complement system function is essential for research, drug development, and clinical diagnostics.
• Current routine diagnostics (e.g., CH50, AH50, turbidimetry, nephelometry, ELISAs) have limitations in detecting functional variants.

Purpose of the Study:

• To review current advances in analytical methods for regulatory complement proteins.
• To assess the impact of new assay strategies and commercial assays on the field.
• To highlight the trend towards faster, more specific, and multiplexed diagnostic tests.

Main Methods:

• Review of commercial assays and research-based assay strategies for complement proteins.
• Discussion of functional assays for fluid-phase and membrane-bound regulatory proteins.
• Inclusion of advances in flow cytometry, functional ELISAs, liposome assays, and genetic analysis.

Main Results:

• Significant progress in functional assays, particularly for fluid-phase and membrane-bound complement proteins.
• Emergence of functional ELISAs and liposome assays as potential replacements for traditional hemolytic assays.
• Genetic analysis provides new insights into complement-related diseases.
• A strong trend towards multiplexing in diagnostic test development.

Conclusions:

• New analytical methods are improving the specificity and efficiency of complement system assessment.
• These advancements support the goals of precision and personalized medicine in complement-related diseases.
• The field is moving towards more sophisticated and versatile diagnostic tools.